Fulgent Genetics (FLGT) FCF Margin (2015 - 2026)

Fulgent Genetics has reported FCF Margin for 12 years, with the latest figure at 32.34% in Q2 2026.

• Quarterly FCF Margin rose 1289.0% year-over-year to 32.34% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 43.07% (down 2329.0% YoY) and the FY2025 annual result came in at 38.49%, down 3170.0% from the prior year.
• FCF Margin retreated to 32.34% in Q2 2026 per FLGT's latest filing, from 2.66% in the prior quarter.
• Over five years, FCF Margin peaked at 57.16% in Q1 2022 and troughed at 20780.75% in Q4 2025.
• A 5-year average of 1154.1% and a median of 3.82% in 2026 frame the typical range for FCF Margin.
• The widest YoY moves for FCF Margin: up 5486 bps in 2025, down 2080862 bps in 2025.
• Over 5 years, FCF Margin stood at 34.07% in 2022, then slumped by 51 bps to 16.77% in 2023, then soared by 66 bps to 27.87% in 2024, then plunged by 74666 bps to 20780.75% in 2025, then surged by 100 bps to 32.34% in 2026.
• According to Business Quant data, FCF Margin over the past three periods registered 32.34%, 2.66%, and 20780.75% for Q2 2026, Q1 2026, and Q4 2025 respectively.